Meningococcal meningitis, typically diagnosed in clinical laboratories by culture, can also be diagnosed by immunological detection of antigens in cerebrospinal fluid (CSF) specimens. For example, the capsular polysaccharides of Neisseria meningitidis can be detected in CSF by counterimmunoelectrophoresis (CIE) (6, 11, 18) , coagglutination (17) , and latex agglutination (15, 23) . The agglutination assays are commercially available for A and C meningococcal groups. Radioimmunoassays have also been used (12) , but some isotopes have relatively short half-lives and waste disposal can be costly. Meningococcal antigens have also been detected in CSF and serum samples by enzyme-linked immunosorbent assay (ELISA) (20) which has proven to be more sensitive than coagglutination, CIE, and latex agglutination for detection of polysaccharide (C. M. Prato, J. E. Sippel, W. R. Sanborn, and N. I. Girgis, Abstr. Annu. Meet. Am. Soc. Microbiol. 1983, C182, p. 342).
The advantages of an ELISA are many and have been reviewed by Yolken (24) . However, like all immunoassays, an effective ELISA system requires immunoglobulin that are specific and have adequate affinities for the antigenic sites. Hyperimmune serum contains antibodies to many determinants whose characteristics vary from batch to batch. Monoclonal antibodies therefore could improve the ELISA by increasing specificity and by providing consistency in diagnostic reagents.
In this study, an ELISA was developed with a mouse monoclonal antibody which was specific for meningococcal pili and reacted with all the group A serotyping strains, making it suitable as a diagnostic reagent for group A meningococcal meningitis. This ELISA was compared with CIE and an ELISA which used rabbit immune serum. * Monoclonal antibody isotyping. Isotypes of the monoclonal antibodies were determined by ELISA; the hybridoma supernatant fluids were diluted 1:10 in the carbonate coating buffer and used to coat the microtiter plates. Dilutions (1:1,000) of rabbit antisera directed against mouse immunoglobulins M, Gi, G2a, G2b, and G3 (Bionetics Laboratories, Charleston, S.C.) were added to the washed plate. After a 1-h incubation (37°C), the plates were washed, 0.1 ml ofgoat anti-rabbit immunoglobulin-alkaline phosphatase conjugate was added at a 1:1,000 dilution, and the assay was completed as above.
Antibody specificity assay. Molecular weight markers and suspensions of live bacterial strains were boiled in sodium dodecyl sulfate-polyacrylamide gel sample buffer (14) for 5 min before application to a 10 to 15% polyacrylamide gradient slab gel. After electrophoresis, the material resolved in the gel was electrophoretically transferred (100 mA for 18 h) to nitrocellulose paper in a Trans-Blot apparatus (Bio-Rad Laboratories, Richmond, Calif.), and an immunoperoxidase assay was performed (3, 21) with the following modifications. The nitrocellulose papers were immersed and gently shaken in blocking buffer (PBS containing 3% fraction V-bovine serum albumin and 10% heat-inactivated calf serum) for 1.5 h at 37°C and then in undiluted hybridoma supernatant fluids or ascitic fluids diluted in blocking buffer for 1.5 h at room temperature. The Assays for bacterial antigens in CSF. Immunoglobulin fractions were precipitated from rabbit antiserum directed against group A meningococci or hybridoma-induced mouse ascitic fluid by adding ammonium sulfate to a concentration of 50% (22) . The precipitate was resolubilized and dialyzed against PBS. The protein concentration was determined (16) , and a 2-mg sample was conjugated to alkaline phosphatase type VII-S (Sigma) by glutaraldehyde fixation (22) . A checkerboard ELISA was performed to determine the optimum dilution of the conjugates; meningococcal strain 4402 was the coating antigen, and the conjugates were diluted from 1:200 to 1:2,000.
The ELISA for bacterial antigens was performed with microtiter plates coated with 0.1 ml of carbonate buffer containing 5.3 ,tg of rabbit antiserum overnight at 4°C. After washing and blocking (1 h at 37°C) with PBS-Tween containing 1 mg of bovine serum albumin per ml, 0.1-ml samples of CSF or meningococcal strain 4402 were added to duplicate wells and incubated for 1 h at 37°C. The plates were washed, and monoclonal or rabbit antibodies conjugated to alkaline phosphatase were added to the wells at a 1:400 and 1:1,000 dilution, respectively, as determined by the checkerboard assay. Incubation was continued for 1 h at 37°C, the plates were washed again, substrate was added, and the color was developed at room temperature.
CIE was performed on the CSF specimens (11) with rabbit hyperimmune antiserum, with group A polysaccharide vaccine (Merieux Institute, Lyon, France) as a positive control and CSF samples known not to contain bacterial antigens as the negative controls.
Pili purification. N. meningitidis 4402 was grown on chocolate agar plates, transferred to Trypticase soy broth, and grown at 37°C for 22 h. The organisms were centrifuged, and the pili were solubilized in 0.15 M ethanolamine, pH 10.5 (1). After centrifugation (17,000 x g for 15 min), the supernatant fluids were precipitated by addition of ammonium sulfate to 10% saturation. The subsequent pellet was resuspended and dialyzed in 75 mM Tris-hydrochloride buffer (pH 7.4) before the protein concentration was determined. A sample of 1.5 F.g of pili was applied to a 10 to 15% sodium dodecyl sulfate-polyacrylamide gel for an immunoblotting assay.
RESULTS
Production of hybridomas. Spleen cells of BALB/c mice immunized with an outer-membrane preparation of N. meningitidis group A strain 4402 were fused with S194/5.XXOBU.14 myeloma cells to produce hybridomas. The hybridoma supernatant fluids were assayed for antibody by an ELISA which used strain 4402 as the antigen. Colonies which secreted antibody directed against strain 4402 were cloned and ascites were produced.
Specificity. The specificity of the monoclonal antibodies was determined by a Western blot analysis. One of the monoclonal antibodies designated 3G7 was of the immunoglobulin G2a subclass and bound to a low-molecular-weight component of ca. 16 ,000. An immunoblot assay with a pilus protein preparation showed that 3G7 was specific for the pilus protein of the meningococcus (Fig. 1) . One of the criteria for choosing a monoclonal antibody suitable for an ELISA was the capability of the antibody to bind all of the group A serotyping strains (25) . Each of the protein and lipopolysaccharide group A serotyping strains was subjected to a Western blot analysis in which the pili from each of the strains reacted with monoclonal antibody 3G7 (Fig. 1) . Some variation in the mobilities of the pili was evident, indicating pilus heterogeneity of the group A meningococcus.
The ability to discriminate between meningococci and other organisms, especially those which may also cause meningitis, is an important characteristic required of an antibody suitable for use as a diagnostic reagent. The monoclonal antibody 3G7 did not bind to E. coli, H. influenzae, Neisseria gonorrhoeae F62, S. typhi 372 or 292, or S. pneumoniae 35 by the Western blot analysis (data not shown).
To determine whether this antibody could be used in a broad-spectrum ELISA, the monoclonal antibody 3G7 was also tested by the immunoblot assay for reactivity against strains from the other major meningococcal serogroups. Four strains did contain pili which bound to 3G7 (Fig. 2) Fig. 3 . The monoclonal antibody detected all of the group A meningococcal strains but not the other organisms, whereas the rabbit anti-group A meningococcal serum was less specific and bound to the group A strains as well as to the B and C meningococcal groups. Each of the organisms was detected by its homologous serum (data not shown).
To optimize conditions by reducing background to a minimum, an ELISA was run in which microtiter wells were J. CLIN. MICROBIOL. coated with monoclonal immunoglobulin purified from ascites or rabbit antiserum. PBS-Tween buffer containing bovine serum albumin was substituted for antigen, and then 3G7 conjugate was added to the plates. The conjugate apparently nonspecifically bound to the wells coated with the monoclonal antibody as evidenced by the developing color, whereas it did not bind to wells coated with rabbit antiserum. Attempts to reduce the background after coating with the monoclonal antibody by blocking with nonimmune rabbit serum were not successful; therefore, rabbit antiserum was used to coat the microtiter plate wells in subsequent tests.
Detection of bacterial antigens in CSF. Detection of the meningococcal antigens in CSF by the ELISA was first performed with the rabbit immunoglobulin conjugate ELISA system. The ELISA controls were CSF from which H. influenza type B organisms were detected. The 25 CSF samples in which meningococcal antigens were detected by the rabbit immunoglobulin conjugate were assayed with the monoclonal antibody conjugate. The means and the standard deviations of the Haemophilus control specimenM and the range of absorbance values determined for the meningococcal specimens of both systems are presented in Table 2 . The 3G7 conjugate was able to detect pili in 21 of the 25 CSF specimens assayed. All Haemophilus specimens were negative by the criteria outlined in Table 2 .
Each of the 25 CSF samples which contained meningococcal antigens was also subjected to a CIE analysis. The CIE assay detected polysaccharide in 16 of 25 CSF specimens. Two of the CSF specimens contained meningococcal antigens which went undetected by the monoclonal antibody ELISA is well as by the CIE assays.
DISCUSSION
The group A meningococcus appears to be the most homogeneous meningococcal group with respect to its complement of outer-membrane proteins (19) Rabbit antigroup A meningococcus was diluted 1:370, and the monoclonal hybridoma 3G7 medium was used undiluted. A450 was determined 1 h after the substrate was added for the wells containing rabbit antiserum and, after 3 h and 20 min, for the wells containing 3G7. The average absorbance was plotted for each organism, and the standard deviation for all the organisms was ± 0.04 U.
The monoclonal antibody used in this assay was directed against the pilus protein. Craven et al. showed that pili were present on bacteria in 96 to 100% of the meningococcal isolates from carriers and patients (5); this observation suggested that our antipilus monoclonal antibody could be used for detection of meningococci in CSF specimens. Although the first 29 amino-terminal amino acids of pilus protein are identical in various gonococcal and meningococcal strains (10) , N. gonorrhoeae pili appear to be antigenically heterogeneous (2) . The pili of the serotyping strains of meningococcal group A are also not identical because differences in electrophoretic migration were observed (Fig. 1) . However, the meningococcal pili share an antigenic site which was recognizable by 3G7. The monoclonal antibody also demonstrated that the pili in other meningococcal serogroups may be dissimilar because it reacted with only one of two group C strains and one of two group Y strains.
The monoclonal antibody conjugate ELISA was able to detect the pilus antigen in 21 of 25 CSF specimens that were positive with the rabbit antibody conjugate ELISA. There are several possible explanations why the monoclonal antibody did not detect pili in four of the specimens; the pili may have been degraded by proteases, the antigenic site of the pili may have been inaccessible, the concentration of pili The hybridoma selected in this study provides a consistent monoclonal antibody which has been shown to act as a specific reagent in the ELISA. This antibody has the advantage over hyperimmune sera because it does not react with organisms such as H. influenza, which is often a problem with other rabbit antiserum preparations (11, 17) . Use of a defined mixture of monoclonal antibodies would be likely to make the assay more sensitive and specific. Currently, we are attempting to prepare suitable monoclonal antibodies against nonpilus antigens of group A meningococci. 
